Published in Stem Cells on June 01, 2014
Concise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye Disease. Stem Cells Transl Med (2015) 1.08
Retinal Organoids from Pluripotent Stem Cells Efficiently Recapitulate Retinogenesis. Stem Cell Reports (2016) 0.87
Loss of MITF expression during human embryonic stem cell differentiation disrupts retinal pigment epithelium development and optic vesicle cell proliferation. Hum Mol Genet (2014) 0.83
Generation of highly enriched populations of optic vesicle-like retinal cells from human pluripotent stem cells. Curr Protoc Stem Cell Biol (2015) 0.83
Stepwise Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells Enables Analysis of Glaucomatous Neurodegeneration. Stem Cells (2016) 0.82
Cellular models and therapies for age-related macular degeneration. Dis Model Mech (2015) 0.82
cGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness. Sci Rep (2016) 0.81
iPS Cells for Modelling and Treatment of Retinal Diseases. J Clin Med (2014) 0.81
Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage. Stem Cells Transl Med (2016) 0.79
Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration. Hum Gene Ther (2016) 0.77
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines. Invest Ophthalmol Vis Sci (2016) 0.77
Current focus of stem cell application in retinal repair. World J Stem Cells (2015) 0.77
iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System. Stem Cells Int (2016) 0.76
Regulation of WNT Signaling by VSX2 During Optic Vesicle Patterning in Human Induced Pluripotent Stem Cells. Stem Cells (2016) 0.75
VSX2 and ASCL1 Are Indicators of Neurogenic Competence in Human Retinal Progenitor Cultures. PLoS One (2015) 0.75
In vitro transdifferentiation of human peripheral blood mononuclear cells to photoreceptor-like cells. Biol Open (2016) 0.75
Use of human pluripotent stem cells to study and treat retinopathies. World J Stem Cells (2015) 0.75
A Method for Sectioning and Immunohistochemical Analysis of Stem Cell-Derived 3-D Organoids. Curr Protoc Stem Cell Biol (2016) 0.75
Genetic chimeras reveal the autonomy requirements for Vsx2 in embryonic retinal progenitor cells. Neural Dev (2015) 0.75
Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy. Curr Protoc Stem Cell Biol (2017) 0.75
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol (1997) 12.11
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell (2012) 3.85
Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A (2009) 3.53
Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiation. Nat Genet (1996) 2.75
In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci (2009) 2.46
Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One (2010) 2.43
Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells (2011) 2.26
Human microphthalmia associated with mutations in the retinal homeobox gene CHX10. Nat Genet (2000) 2.13
Developmental expression of a novel murine homeobox gene (Chx10): evidence for roles in determination of the neuroretina and inner nuclear layer. Neuron (1994) 2.02
Eye development: a view from the retina pigmented epithelium. Bioessays (2004) 1.79
Chx10 repression of Mitf is required for the maintenance of mammalian neuroretinal identity. Development (2004) 1.79
Extraocular mesenchyme patterns the optic vesicle during early eye development in the embryonic chick. Development (2000) 1.72
A regulatory loop involving PAX6, MITF, and WNT signaling controls retinal pigment epithelium development. PLoS Genet (2012) 1.72
Eye morphogenesis and patterning of the optic vesicle. Curr Top Dev Biol (2010) 1.60
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
Transdifferentiation of the retina into pigmented cells in ocular retardation mice defines a new function of the homeodomain gene Chx10. Development (2004) 1.58
Otx genes are required for tissue specification in the developing eye. Development (2001) 1.56
Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes. PLoS One (2010) 1.54
Alternative promoter use in eye development: the complex role and regulation of the transcription factor MITF. Development (2008) 1.50
Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci (2012) 1.50
Cell fate determination in the vertebrate retina. Trends Neurosci (2012) 1.41
Beta-catenin controls differentiation of the retinal pigment epithelium in the mouse optic cup by regulating Mitf and Otx2 expression. Development (2009) 1.39
Genetic rescue of cell number in a mouse model of microphthalmia: interactions between Chx10 and G1-phase cell cycle regulators. Development (2003) 1.35
Spatial and temporal regulation of Wnt/beta-catenin signaling is essential for development of the retinal pigment epithelium. Dev Biol (2009) 1.34
Molecular mechanisms of optic vesicle development: complexities, ambiguities and controversies. Dev Biol (2007) 1.30
Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med (2013) 1.27
Eye development. Curr Top Dev Biol (2010) 1.27
Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J Tissue Eng Regen Med (2012) 1.27
Efficient stage-specific differentiation of human pluripotent stem cells toward retinal photoreceptor cells. Stem Cells (2012) 1.27
Regulation of proliferation, cell fate specification and differentiation by the homeodomain proteins Prox1, Six3, and Chx10 in the developing retina. Cell Cycle (2003) 1.25
Vsx2 in the zebrafish retina: restricted lineages through derepression. Neural Dev (2009) 1.23
Fibroblast growth factors are necessary for neural retina but not pigmented epithelium differentiation in chick embryos. Development (1997) 1.22
Embryology of the eye and its adnexae. Dev Ophthalmol (1992) 1.21
Retinal pigment epithelium development, plasticity, and tissue homeostasis. Exp Eye Res (2013) 1.19
Brief report: self-organizing neuroepithelium from human pluripotent stem cells facilitates derivation of photoreceptors. Stem Cells (2013) 1.11
Comparative RNA-seq analysis in the unsequenced axolotl: the oncogene burst highlights early gene expression in the blastema. PLoS Comput Biol (2013) 1.11
Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods (2007) 1.11
A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med (2013) 1.09
Patterning the optic neuroepithelium by FGF signaling and Ras activation. Development (2001) 1.09
Functional analysis of serially expanded human iPS cell-derived RPE cultures. Invest Ophthalmol Vis Sci (2013) 1.07
The developing and evolving retina: using time to organize form. Brain Res (2007) 1.07
Identification of novel mutations and sequence variants in the SOX2 and CHX10 genes in patients with anophthalmia/microphthalmia. Mol Vis (2008) 1.06
Secreted inducers in vertebrate eye development: more functions for old morphogens. Curr Opin Neurobiol (2006) 1.04
Inactivation of the zebrafish homologue of Chx10 by antisense oligonucleotides causes eye malformations similar to the ocular retardation phenotype. Mech Dev (1997) 1.02
Fgf19 is required for zebrafish lens and retina development. Dev Biol (2007) 0.97
Mutations in the CHX10 gene in non-syndromic microphthalmia/anophthalmia patients from Qatar. Clin Genet (2007) 0.96
Delayed expression of the Crx gene and photoreceptor development in the Chx10-deficient retina. Invest Ophthalmol Vis Sci (2004) 0.92
Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells. Stem Cells Transl Med (2013) 0.92
Partial rescue of the ocular retardation phenotype by genetic modifiers. J Neurobiol (2000) 0.89
Vsx2 controls eye organogenesis and retinal progenitor identity via homeodomain and non-homeodomain residues required for high affinity DNA binding. PLoS Genet (2012) 0.85
Focus on molecules: homeobox protein Chx10. Exp Eye Res (2007) 0.84
Otx but not Mitf transcription factors are required for zebrafish retinal pigment epithelium development. PLoS One (2012) 0.84
VSX2 mutations in autosomal recessive microphthalmia. Mol Vis (2011) 0.81
Mapping of genetic modifiers affecting the eye phenotype of ocular retardation (Chx10or-J) mice. Mamm Genome (2006) 0.78
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Human DNA methylomes at base resolution show widespread epigenomic differences. Nature (2009) 34.27
Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature (2009) 24.41
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
The NIH Roadmap Epigenomics Mapping Consortium. Nat Biotechnol (2010) 13.99
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
ProbeMatch: rapid alignment of oligonucleotides to genome allowing both gaps and mismatches. Bioinformatics (2009) 13.34
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
RNA-Seq gene expression estimation with read mapping uncertainty. Bioinformatics (2009) 10.74
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat Biotechnol (2003) 9.15
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell (2010) 8.74
Whole-genome analysis of histone H3 lysine 4 and lysine 27 methylation in human embryonic stem cells. Cell Stem Cell (2007) 8.59
Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol (2006) 8.28
MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell (2009) 8.14
Feeder-independent culture of human embryonic stem cells. Nat Methods (2006) 7.61
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A (2010) 7.31
Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09
Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods (2005) 6.37
BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol (2002) 6.20
Chemically defined conditions for human iPSC derivation and culture. Nat Methods (2011) 5.84
Homologous recombination in human embryonic stem cells. Nat Biotechnol (2003) 5.77
Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res (2003) 5.12
NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell (2008) 4.88
EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments. Bioinformatics (2013) 4.79
Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A (2003) 4.67
Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood (2004) 4.32
Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell (2013) 3.81
Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res (2007) 3.56
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci U S A (2013) 3.53
Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A (2009) 3.53
Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells (2005) 3.38
Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med (2006) 3.07
Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A (2008) 2.99
Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res (2012) 2.91
Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells (2005) 2.78
Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell (2010) 2.69
Caspase activity mediates the differentiation of embryonic stem cells. Cell Stem Cell (2008) 2.68
Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood (2006) 2.66
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents. Am J Physiol Heart Circ Physiol (2011) 2.65
A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell (2010) 2.58
Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat (2002) 2.52
High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells (2003) 2.42
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci U S A (2011) 2.41
Proteomic and phosphoproteomic comparison of human ES and iPS cells. Nat Methods (2011) 2.39
Mass spectrometry identifies and quantifies 74 unique histone H4 isoforms in differentiating human embryonic stem cells. Proc Natl Acad Sci U S A (2008) 2.29
Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells (2011) 2.26
Pluripotent stem cell lines. Genes Dev (2008) 2.25
Ronin is essential for embryogenesis and the pluripotency of mouse embryonic stem cells. Cell (2008) 2.21
One versus two venous anastomoses in microvascular free flap surgery. Plast Reconstr Surg (2010) 2.20
Oceanic spawning ecology of freshwater eels in the western North Pacific. Nat Commun (2011) 2.20
Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology (2003) 2.15
Frameless image-guided radiosurgery for initial treatment of typical trigeminal neuralgia. World Neurosurg (2011) 2.11
FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell Stem Cell (2011) 2.11
A germ cell origin of embryonic stem cells? Development (2005) 2.09
Defined substrates for human embryonic stem cell growth identified from surface arrays. ACS Chem Biol (2007) 2.08
Quantitative selection of DNA aptamers through microfluidic selection and high-throughput sequencing. Proc Natl Acad Sci U S A (2010) 2.01
Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci U S A (2009) 1.95
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood (2011) 1.92
The accuracy of stereolithography in planning craniofacial bone replacement. J Craniofac Surg (2003) 1.75
Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat Protoc (2012) 1.74
Deep-ocean origin of the freshwater eels. Biol Lett (2010) 1.72
Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency. Cell Res (2011) 1.72
Race and the intensive care unit: disparities and preferences for end-of-life care. Crit Care Med (2003) 1.68
Reduced radiation exposure with the use of an air retrograde pyelogram during fluoroscopic access for percutaneous nephrolithotomy. J Endourol (2011) 1.61
iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59
Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme. J Virol (2003) 1.57
Y chromosome azoospermia factor region microdeletions and recurrent pregnancy loss. Am J Obstet Gynecol (2008) 1.52
Conserved regulation of MAP kinase expression by PUF RNA-binding proteins. PLoS Genet (2007) 1.51
Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci (2012) 1.50